S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

• Maurizio Martelli,
• Luca Ceriani,
• Emanuele Zucca,
• Irina Kryachok,
• Giovannino Ciccone,
• Umberto Ricardi,
• Barbara Botto,
• Monica Balzarotti,
• Alessandra Tucci,
• Sara Veronica Usai,
• Elsa Pennese,
• Luca Arcaini,
• Anna Dabrowska-Iwanicka,
• Andrés José María Ferreri,
• Francesco Marli,
• Weili Zhao,
• David Hodgson,
• Codruta Ionescu,
• Luigi Rigacci,
• Claudia Cellini,
• Caterina Stelitano,
• Francesco Zaja,
• Attilio Guarini,
• Michele Spina,
• Alexander Fossa,
• Kate Cwynarski,
• N. George Mikhaeel,
• Mats Jerkeman,
• Andrea Janíková,
• Andreas Huettmann,
• Maria Gomes Da Silva,
• Don Stevens,
• Luigi Petrucci,
• Sally Barrington,
• Bogdan Malkowski,
• Ur Metser,
• Annibale Versari,
• Oreste Bagni,
• Stephane Chauvie,
• Kelly Cozens,
• Sonia Perticone,
• Nicoletta Ielmini,
• Franco Cavalli,
• Mary Gosodarowicz,
• Peter W. Johnson,
• Andrew Davies

Affiliations

Maurizio Martelli

1 Sapienza University, Hematology Department of translational and Precision Medicine, Rome, Italy

Luca Ceriani

2 Ente Ospedaliero Cantnale, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland

Emanuele Zucca

3 Institute of Oncology Research, Bellinzona, Switzerland

Irina Kryachok

6 National Cancer Institute, Oncohematology, Kyev, Ukraine

Giovannino Ciccone

7 CPO Piemonte and University of Turin, Reference Centre for Epidemiology and Cancer Prevention, Turin, Italy

Umberto Ricardi

8 University of Turin, Department of Oncology, Turin, Italy

Barbara Botto

9 AO Città della Salute e della Scienza, Department of Oncology and Hematology, Turin, Italy

Monica Balzarotti

10 IRCCS Humanitas Research Hospital, UO Ematologia, Milan Rozzano, Italy

Alessandra Tucci

11 ASST Spedali Civili di Brescia, Brescia, Italy

Sara Veronica Usai

12 Azienda Ospedaliera Brotzu - Ospedale Oncologico Businco, Medical Oncology Department, Cagliari, Italy

Elsa Pennese

13 Presidio Ospedaliero Spirito Santo, Centro diagnosi e terapia dei linfomi, Pescara, Italy

Luca Arcaini

14 IRCCS Policlinico San Matteo, Hematology Department, Pavia, Italy

Anna Dabrowska-Iwanicka

15 Maria Sklodowska-Curie National Research Institute of Oncology, Department of Lymphoid Malignancies, Warszawa, Poland

Andrés José María Ferreri

16 IRCCS San Raffaele Scientific Institute, Onco-Hematology Department, Milan, Italy

Francesco Marli

17 AUSL di Reggio Emilia Arcispedale Santa Maria Nuova, Hematology Department, Reggio Emilia, Italy

Weili Zhao

18 Rui Jin Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, Italy

David Hodgson

19 Princess Margaret Hospital, Toronto, Canada

Codruta Ionescu

20 Inselspital, Department of Radiation Oncology, Bern, Switzerland

Luigi Rigacci

21 Policlinico Careggi, Hematology Department, Florence, Italy

Claudia Cellini

22 AUSL Romagna, Onco-Hematology Department, Ravenna, Italy

Caterina Stelitano

23 AO Bianchi-Melacrino-Morelli di Reggio Calabria, Reggio Calabria, Italy

Francesco Zaja

24 Azienda Sanitaria Universitaria Integrata di Udine e Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy

Attilio Guarini

25 IRCCS Istituto Tumori Giovanni Paolo II, Clinical and Experimental Oncology Department, Bari, Italy

Michele Spina

26 Centro di Riferimento Onclogico, Divison of Medical Oncology, Aviano, Italy

Alexander Fossa

27 Oslo University Hospital, Department of Oncology

Kate Cwynarski

28 University College London Hospitals NHS Trust, Department Of Haematology Royal Free Hospital, London, United Kingdom

N. George Mikhaeel

29 Guy’s Cancer Centre, Guy’s & St Thomas’ NHS Trust and King’s College University, London, United Kingdom

Mats Jerkeman

30 Lund University Hospital, Lund, Sweden

Andrea Janíková

31 University Hospital Brno, Brno, Czech Republic

Andreas Huettmann

32 Essen University Hospital, Hematology Department, Essen, Germany

Maria Gomes Da Silva

33 Portuguese Institute of Oncology, Department of Hematology, Lisbon, Portugal

Don Stevens

34 Norton Cancer Institute, Louisville, United States

Luigi Petrucci

35 Sapienza University, Hematology Department of translational and Precision Medicine, Rome, Italy

Sally Barrington

36 King’s College London & St Thomas’ Hospital, London, United Kingdom

Bogdan Malkowski

37 Nicolaus Copernicus University, Department of Nuclear Medicine, Torun, Poland

Ur Metser

38 University Health Network Princess Margaret Hospital, Department of Medical Imaging, Toronto, Canada

Annibale Versari

39 Azienda USL-IRCCS of Reggio Emilia, Nuclear Medicine - Oncology and High Technology Depatment, Reggio Emilia, Italy

Oreste Bagni

40 ASL Latina, Nuclear Medicine Department, Latina, Italy

Stephane Chauvie

41 AO Santa Croce e Carle, Medical Physic Division, Cuneo, Italy

Kelly Cozens

42 University of Southampton, Clinical Trial Unit, Southampton, United Kingdom

Sonia Perticone

43 Fondazione Italiana Linfomi, Alessandria, Italy

Nicoletta Ielmini

44 Institute of Oncology Research, IELSG, Bellinzona, Switzerland

Franco Cavalli

3 Institute of Oncology Research, Bellinzona, Switzerland

Mary Gosodarowicz

45 University Health Network Princess Margaret Hospital, Toronto, Canada

Peter W. Johnson

46 University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, United Kingdom

Andrew Davies

47 Southampton CRUK/NCRI Experimental Cancer Medicines Centre, Southampton, United Kingdom